Peripartum Clostridium difficile infection: case series and review of the literature

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 4, 2008, Pages 332-337

  Garey, Kevin W ^a,b   Jiang, Zhi Dong ^c   Yadav, Yashoo ^b   Mullins, Bridget ^a   Wong, Keith ^a   Dupont, Herbert L ^b,c,d  

^a UNIVERSITY OF HOUSTON   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

case series; Clostridium difficile; diarrhea; pregnancy

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CEFAZOLIN; CEFOXITIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; CLOSTRIDIUM TOXIN; COLESTYRAMINE; LEVOFLOXACIN; LOPERAMIDE; METRONIDAZOLE; RIFAXIMIN; VANCOMYCIN;

ABDOMINAL PAIN; ACUTE HEMORRHAGIC PANCREATITIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CDTA GENE; CDTB GENE; CESAREAN SECTION; CLOSTRIDIUM DIFFICILE; COLITIS; COLON RESECTION; COLONOSCOPY; COLOSTOMY; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DRUG WITHDRAWAL; FECES ANALYSIS; GALLSTONE; HOSPITALIZATION; HUMAN; ILEOSTOMY; NONHUMAN; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; REVIEW; RISK FACTOR; SINGLE DRUG DOSE; STRAIN IDENTIFICATION; TCDA GENE; TCDB GENE; TCDC GENE; TREATMENT OUTCOME;

ADULT; ANTI-INFECTIVE AGENTS; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; LENGTH OF STAY; METRONIDAZOLE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS;

EID: 52949136989     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.05.001     Document Type: Review

References (36)

1. Poutanen S.M., and Simor A.E. Clostridium difficile-associated diarrhea in adults. CMAJ 171 (2004) 51-58
2. Barbut F., and Petit J.C. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 7 (2001) 405-410
3. McDonald L.C., Killgore G.E., Thompson A., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353 (2005) 2433-2441
4. Severe Clostridium difficile-associated disease in populations previously at low risk: four states, 2005. MMWR Morb Mortal Wkly Rep 54 (2005) 1201-1205
5. Jamieson D.J., Theiler R.N., and Rasmussen S.A. Emerging infections and pregnancy. Emerg Infect Dis 12 (2006) 1638-1643
6. Read K.M., Kennedy-Andrews S., and Gordon D.L. Amoebic liver abscess in pregnancy. Aust N Z J Obstet Gynaecol 41 (2001) 236-237
7. Barbut F., Kajzer C., Planas N., and Petit J.C. Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 31 (1993) 963-967
8. Katz D.A., Lynch M.E., and Littenberg B. Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea. Am J Med 100 (1996) 487-495
9. Peterson L.R., Kelly P.J., and Nordbrock H.A. Role of culture and toxin detection in laboratory testing for diagnosis of Clostridium difficile-associated diarrhea. Eur J Clin Microbiol Infect Dis 15 (1996) 330-336
10. Gumerlock P.H., Tang Y.J., Meyers F.J., and Silva Jr. J. Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces. Rev Infect Dis 13 (1991) 1053-1060
11. Spigaglia P., and Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40 (2002) 3470-3475
12. Stubbs S., Rupnik M., Gibert M., Brazier J., Duerden B., and Popoff M. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 186 (2000) 307-312
13. Alef K. Clostridium difficile-associated disease. Implications for midwifery practice. J Nurse Midwifery 44 (1999) 19-29
14. Arsura E.L., Fazio R.A., and Wickremesinghe P.C. Pseudomembranous colitis following prophylactic antibiotic use in primary cesarean section. Am J Obstet Gynecol 151 (1985) 87-89
15. Clark K.H., Jernigan T.W., and Haley T. Antibiotic-associated pseudomembranous colitis with toxic megacolon after cesarean section. J Tenn Med Assoc 86 (1993) 57-58
16. Duff P. Pseudomembranous enterocolitis after cesarean delivery. Am J Obstet Gynecol 153 (1985) 926
17. Ghai S., Ghai V., and Sunderji S. Fulminant postcesarean Clostridium difficile pseudomembranous colitis. Obstet Gynecol 109 (2007) 541-543
18. McDonald L.C., Coignard B., Dubberke E., Song X., Horan T., and Kutty P.K. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 28 (2007) 140-145
19. Pepin J., Alary M.E., Valiquette L., et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 40 (2005) 1591-1597
20. Pepin J., Valiquette L., Alary M.E., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171 (2004) 466-472
21. Szekeres-Bartho J. Immunological relationship between the mother and the fetus. Int Rev Immunol 21 (2002) 471-495
22. Poxton I.R., McCoubrey J., and Blair G. The pathogenicity of Clostridium difficile. Clin Microbiol Infect 7 (2001) 421-427
23. Pothoulakis C., and Lamont J.T. Microbes and microbial toxins: paradigms for microbial-mucosal interactions II: the integrated response of the intestine to Clostridium difficile toxins. Am J Physiol Gastrointest Liver Physiol 280 (2001) G178-G183
24. Canny G., Drudy D., Macmathuna P., O'Farrelly C., and Baird A.W. Toxigenic C difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetrical. Life Sci 78 (2006) 920-925
25. He D., Sougioultzis S., Hagen S., et al. Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation. Gastroenterology 122 (2002) 1048-1057
26. Jefferson K.K., Smith Jr. M.F., and Bobak D.A. Roles of intracellular calcium and NF-kappa B in the Clostridium difficile toxin A-induced up-regulation and secretion of IL-8 from human monocytes. J Immunol 163 (1999) 5183-5191
27. Johal S.S., Solomon K., Dodson S., Borriello S.P., and Mahida Y.R. Differential effects of varying concentrations of Clostridium difficile toxin A on epithelial barrier function and expression of cytokines. J Infect Dis 189 (2004) 2110-2119
28. Steiner T.S., Flores C.A., Pizarro T.T., and Guerrant R.L. Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin Diagn Lab Immunol 4 (1997) 719-722
29. Tixier E., Lalanne F., Just I., Galmiche J.P., and Neunlist M. Human mucosa/submucosa interactions during intestinal inflammation: involvement of the enteric nervous system in interleukin-8 secretion. Cell Microbiol 7 (2005) 1798-1810
30. Warny M., Keates A.C., Keates S., et al. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J Clin Invest 105 (2000) 1147-1156
31. Warny M., Pepin J., Fang A., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366 (2005) 1079-1084
32. Geric B., Rupnik M., Gerding D.N., Grabnar M., and Johnson S. Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol 53 (2004) 887-894
33. McEllistrem M.C., Carman R.J., Gerding D.N., Genheimer C.W., and Zheng L. A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis 40 (2005) 265-272
34. Geric B., Carman R.J., Rupnik M., et al. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis 193 (2006) 1143-1150
35. McNeeley Jr. S.G., Anderson G.D., and Sibai B.M. Clostridium difficile colitis associated with single-dose cefazolin prophylaxis. Obstet Gynecol 66 (1985) 737-738
36. James A.H., Katz V.L., Dotters D.J., and Rogers R.G. Clostridium difficile infection in obstetric and gynecologic patients. South Med J 90 (1997) 889-892